title: Norepinephrine preferentially modulates memory CD8 T cell function inducing inflammatory cytokine production and reducing proliferation in response to activation.
abstract: BACKGROUND
  Norepinephrine (NE) is one of the primary catecholamines of the sympathetic nervous system released during a stress response and plays an important role in modulating immune function. NE binds to the adrenergic receptors on immune cells, including T cells, resulting in either suppressed or enhanced function depending on the type of cell, activation status of the cell, duration of NE exposure and concentration of NE. Here, we aim to analyze the effects of NE on the functionality of naïve (Tn), central memory (Tcm) and effector memory (Tem) CD8 T cells.
  
  
  METHODS
  We isolated CD8 T cell subsets from healthy human adults and treated cells in vitro with NE (1×10(-6)M) for 16h; we then stimulated NE treated and untreated CD8 T cell subsets with antibodies for CD3 and CD28 for 24 and 72h. We assessed the level of beta-2 adrenergic receptor (ADRB2) expression in these cells as well as global gene expression changes in NE treated Tcm cells by microarray analysis. Altered expressed genes after NE treatment were identified and further confirmed by RT-qPCR, and by ELISA for protein changes. We further determined whether the observed NE effects on memory CD8 T cells are mediated by ADRB2 using specific adrenergic receptor agonist and antagonists. Finally, we examined the levels of mRNA and protein of the NE-induced genes in healthy adults with high serum levels of NE (>150pg/mL) compared to low levels (<150pg/mL).
  
  
  RESULTS
  We found that memory (Tcm and Tem) CD8 T cells expressed a significantly higher level of ADRB2 compared to naïve cells. Consequently, memory CD8 T cells were significantly more sensitive than naïve cells to NE induced changes in gene expressions in vitro. Global gene expression analysis revealed that NE induced an elevated expression of inflammatory cytokines and chemokines in resting and activated memory CD8 T cells in addition to a reduced expression of growth-related cytokines. The effects of NE on memory CD8 T cells were primarily mediated by ADRB2 as confirmed by the adrenergic receptor agonist and antagonist assays. Finally, individuals with high serum levels of NE had similar elevated gene expressions observed in vitro compared to the low NE group.
  
  
  CONCLUSIONS
  Our results demonstrate that NE preferentially modulates the functions of memory CD8 T cells by inducing inflammatory cytokine production and reducing activation-induced memory CD8 T cell expansion.
authors: School of Nursing, University of Pennsylvania, United States; Laboratory of Molecular Biology & Immunology, National Institute on Aging, National Institutes of Health, United States.
authors: Christina
authors: C
authors: Slota
authors: Laboratory of Molecular Biology & Immunology, National Institute on Aging, National Institutes of Health, United States.
authors: Alvin
authors: A
authors: Shi
authors: Laboratory of Molecular Biology & Immunology, National Institute on Aging, National Institutes of Health, United States.
authors: Guobing
authors: G
authors: Chen
authors: Nursing Department, National Institutes of Health Clinical Center, United States.
authors: Margaret
authors: M
authors: Bevans
authors: Laboratory of Molecular Biology & Immunology, National Institute on Aging, National Institutes of Health, United States. Electronic address: wengn@mail.nih.gov.
authors: Nan-ping
authors: NP
authors: Weng
mesh_terms: D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects* / Q000378:metabolism; D049109:Cell Proliferation / Q000187:drug effects*; D016207:Cytokines / Q000378:metabolism*; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology*; D018343:Receptors, Adrenergic, beta-2 / Q000378:metabolism
chemical_list: D016207:Cytokines; D018343:Receptors, Adrenergic, beta-2; D009638:Norepinephrine
keywords: CD8 T cells; Inflammation; Norepinephrine; Stress
references: Psychosom Med. 1994 Jul-Aug;56(4):290-5
references: 7972610
references: Immunol Lett. 2003 Dec 15;90(2-3):165-72
references: 14687720
references: Psychosom Med. 1997 May-Jun;59(3):251-6
references: 9178336
references: J Immunol. 1997 Nov 15;159(10):4857-67
references: 9366411
references: Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):990-2
references: 9517622
references: Immunity. 1998 May;8(5):591-9
references: 9620680
references: Immunol Today. 1998 Sep;19(9):409-13
references: 9745204
references: J Immunol. 1999 Sep 1;163(5):2492-9
references: 10452985
references: Psychosom Med. 2005 Jul-Aug;67(4):638-42
references: 16046380
references: J Neuroimmunol. 2005 Sep;166(1-2):144-57
references: 16026859
references: Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
references: 16199517
references: J Leukoc Biol. 2006 Jun;79(6):1093-104
references: 16531560
references: Arthritis Res Ther. 2006;8(5):R138
references: 16889669
references: Brain Behav Immun. 2007 Nov;21(8):1009-18
references: 17889502
references: J Immunol. 2008 Nov 1;181(9):5842-6
references: 18941172
references: Neuroimmunomodulation. 2008;15(4-6):251-9
references: 19047802
references: Immunity. 2009 Jun 19;30(6):912-25
references: 19523850
references: BMC Immunol. 2009;10:62
references: 19968887
references: Rev Esc Enferm USP. 2011 Jun;45(3):722-9
references: 21710081
references: Brain Behav Immun. 2012 Feb;26(2):195-200
references: 21855626
references: Psychoneuroendocrinology. 2012 Sep;37(9):1345-68
references: 22727761
references: Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:268-76
references: 23085509
references: Annu Rev Immunol. 2004;22:745-63
references: 15032595
references: Am J Geriatr Psychiatry. 2004 May-Jun;12(3):281-6
references: 15126229
references: Biochem Pharmacol. 1986 Apr 1;35(7):1137-42
references: 3008755
references: Clin Chem. 1986 Nov;32(11):2030-3
references: 3096593
references: J Neuroimmunol. 1989 Sep;24(1-2):155-62
references: 2572605
references: Am J Physiol. 1990 Jan;258(1 Pt 1):E191-202
references: 2154117
references: Ann N Y Acad Sci. 1990;594:253-69
references: 2165759
references: Brain Behav Immun. 2014 Feb;36:118-27
references: 24513872
references: J Exp Med. 2014 Dec 15;211(13):2583-98
references: 25422496
references: J Biol Chem. 2000 Jan 14;275(2):867-74
references: 10625620
references: Annu Rev Med. 2000;51:245-70
references: 10774463
references: J Neurochem. 2000 Dec;75(6):2464-71
references: 11080198
references: Immunol Today. 2000 Nov;21(11):539-42
references: 11094255
references: Brain Behav Immun. 2000 Dec;14(4):239-55
references: 11120594
references: J Immunol. 2001 Jan 1;166(1):232-40
references: 11123297
references: Pharmacol Rev. 2000 Dec;52(4):595-638
references: 11121511
references: Ann N Y Acad Sci. 2000;917:307-21
references: 11268358
references: Pharmacol Rev. 2001 Dec;53(4):487-525
references: 11734616
references: J Neuroimmunol. 2002 Feb;123(1-2):180-7
references: 11880162
references: Brain Behav Immun. 2002 Aug;16(4):290-332
references: 12096881
references: Brain Behav Immun. 2003 Feb;17(1):55-67
references: 12615050
references: Nat Genet. 2003 Jul;34(3):267-73
references: 12808457
references: Trends Immunol. 2003 Aug;24(8):444-8
references: 12909458
references: Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3043-7
references: 8610165